載入...
Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
Renal impairment is a typical side effect of tacrolimus (Tac) treatment in liver transplant (LT) recipients. One strategy to avoid renal dysfunction is to increase the concentration/dose (C/D) ratio by improving drug bioavailability. LT recipients converted from standard-release Tac to MeltDose(®) T...
Na minha lista:
| 發表在: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356524/ https://ncbi.nlm.nih.gov/pubmed/32492783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061654 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|